Human papilloma virus-specific T cells can be generated from naïve T cells for use as an immunotherapeutic strategy for immunocompromised patients.

Document Type

Journal Article

Publication Date

1-10-2018

Journal

Cytotherapy

DOI

10.1016/j.jcyt.2017.11.010

Peer Reviewed

1

Find in your library

Share

COinS